Detalles de la búsqueda
1.
Investigation of biomarkers to predict outcomes in allogeneic hematopoietic stem cell transplantation.
Cytotherapy
; 2024 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38625069
2.
Prognostic significance of the CFA ratio for newly diagnosed acute myeloid leukemia: A multicenter retrospective study.
Hematol Oncol
; 42(1): e3228, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37731313
3.
Comparison of cryoprotectants in hematopoietic cell infusion-related adverse events.
Transfusion
; 62(6): 1280-1288, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35396716
4.
Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS: a KSGCT prospective study.
Ann Hematol
; 101(12): 2719-2729, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36149461
5.
Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysis.
Ann Hematol
; 100(11): 2763-2771, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34357435
6.
Allogeneic hematopoietic stem cell transplantation at the first remission for younger adults with FLT3-internal tandem duplication AML: The JALSG AML209-FLT3-SCT study.
Cancer Sci
; 111(7): 2472-2481, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32391628
7.
Impact of Cytomegalovirus Reactivation and Natural Killer Reconstitution on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Analysis.
Biol Blood Marrow Transplant
; 26(1): 171-177, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31563574
8.
Outcomes and Prognostic Factors for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A KSGCT Multicenter Analysis.
Biol Blood Marrow Transplant
; 26(5): 998-1004, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31962165
9.
A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort.
Biol Blood Marrow Transplant
; 26(1): 162-170, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31536824
10.
Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study.
Transfusion
; 60(5): 1015-1023, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32306410
11.
Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.
Biol Blood Marrow Transplant
; 25(9): 1851-1858, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31129353
12.
Allogeneic hematopoietic cell transplantation for patients with a history of multiple relapses of acute myeloid leukemia.
Ann Hematol
; 98(9): 2179-2186, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31203422
13.
Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study.
Ann Hematol
; 98(1): 83-91, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30251205
14.
Upfront allogeneic hematopoietic cell transplantation (HCT) versus remission induction chemotherapy followed by allogeneic HCT for acute myeloid leukemia with multilineage dysplasia: A propensity score matched analysis.
Am J Hematol
; 94(1): 103-110, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30370944
15.
Additional Cytogenetic Abnormalities with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia on Allogeneic Stem Cell Transplantation in the Tyrosine Kinase Inhibitor Era.
Biol Blood Marrow Transplant
; 24(10): 2009-2016, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29908230
16.
Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia.
Biol Blood Marrow Transplant
; 24(4): 717-725, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29197675
17.
Refractory Graft-Versus-Host Disease-Free, Relapse-Free Survival as an Accurate and Easy-to-Calculate Endpoint to Assess the Long-Term Transplant Success.
Biol Blood Marrow Transplant
; 24(7): 1521-1526, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29476953
18.
Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).
Ann Hematol
; 97(11): 2173-2183, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29978286
19.
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL.
Ann Hematol
; 97(9): 1535-1545, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29694642
20.
Released washed platelet concentrates are effective and safe in patients with a history of transfusion reactions.
Transfus Apher Sci
; 57(6): 746-751, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30224152